Home > Information
Information
- Apr. 12, 2022
- Hiroyoshi Nishikawa honored with a prestigious Commendation from the Minister of Education, Culture, Sports, Science and Technology
- Mar. 25, 2022
- Franco-Japanese immuno-oncology webinar 2st session held
- Mar. 18, 2022
- Aberrant activation of cell cycle-related kinases in uterine leiomyosarcoma
- Mar. 3, 2022
- Discovery of splicing vulnerability and novel therapy in RAS Q61 cancers -Nature-
- Feb. 21, 2022
- Memorandum of Understanding signed with Peking University First Hospital
- Feb. 1, 2022
- Recruitment of Postdoctoral Fellow
- Feb. 1, 2022
- Virtual Meeting with Tata Memorial Centre of India, Celebrating the Conclusion of Memorandum of Understanding
- Jan. 28, 2022
- Franco-Japanese immuno-oncology webinar 1st session held
- Jan. 28, 2022
- Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
- Jan. 18, 2022
- Tatsuhiro Shibata awarded Princess Takamatsu Cancer Research Fund Prize
- Jan. 11, 2022
- Joint Statement Announced upon the visit by Prime Minister of Viet Nam
- Jan. 6, 2022
- Franco-Japanese immuno-oncology webinar series
- Dec. 24, 2021
- Depletion of central memory CD8+T cells might impede the antitumor therapeutic effect of Mogamulizumab
- Dec. 23, 2021
- Webinar for “Russo -Japanese Joint Symposium”
- Dec. 23, 2021
- Launch of an Asian international collaborative prospective study on 6 advanced cancers common in Asia
- Dec. 21, 2021
- CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,
identified using LC-SCRUM-Asia genomic screening platform - Dec. 14, 2021
- Endoscopists at the National Cancer Center Hospital selected as world-class experts in endoscopic mucosal resection (EMR) by Expertscape
- Dec. 1, 2021
- Joint Statement Issued with National Cancer Hospital, Viet Nam
- Nov. 22, 2021
- Memorandum of Understanding signed with Frederick National Laboratory for Cancer Research
- Nov. 15, 2021
- Activated WNT/β-catenin pathway induces resistance to immunotherapies in cancers harboring high tumor mutation burden
- Nov. 12, 2021
- Study shows efficacy of dual-HER2 targeted therapy for patients with HER2-positive colorectal cancer
- Nov. 11, 2021
- First in-patient transplantation of iPS cell-derived natural killer cells to treat ovarian cancer
- Oct. 28, 2021
- Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma
- Oct. 27, 2021
- Global whole genome sequencing research on esophageal cancers reveals
carcinogenic mechanisms specific to Japan - Oct. 27, 2021
- For future collaboration of Japan-China-Korea NCCs
- Oct. 20, 2021
- MASTER KEY ASIA
- Oct. 14, 2021
- Breakthrough Discovery on the Structure and Activation Mechanism of ALK
- Oct. 7, 2021
- National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2022 (Oncology)”
- Sep. 8, 2021
- Shun-ichi Watanabe awarded the Ginsberg Lectureship Award for Surgery at the 2021 World Conference on Lung Cancer
- Sep. 6, 2021
- Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
- Aug. 17, 2021
- Whole Genome Sequencing Finds Therapeutic Targets for Linitis Plastica-type Gastric Cancer
- Aug. 16, 2021
- Webinar with Neijiang, China
- Jul. 20, 2021
- Japan-China-Korea NCCs Top Meeting
- Jun. 30, 2021
- Initiation of the 4th-stage industry-academia collaborative Cancer Genome Screening Project for Individualized Medicine in Japan, SCRUM-Japan
- Jun. 22, 2021
- Webinar with the Fourth Hospital of Hebei Medical University
- Jun. 14, 2021
- Visit by Young Leaders’ Program from Nagoya University
- Jun. 2, 2021
- SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
- May 27, 2021
- MOU concluded with Thai Society of Clinical Oncology (TSCO)
- May 17, 2021
- "MONSTAR-SCREEN" has joined as an official member program in the International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC-ARGO)
- May 14, 2021
- NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
- Apr. 27, 2021
- National Cancer Center Japan and Pharmaceuticals and Medical Devices Agency Endorsed as a joint Center of Excellence by APEC
- Apr. 23, 2021
- Cancer Statistics in Japan; Table download
- Apr. 9, 2021
- Dr Hiroyuki Mano was awarded the 49th Fondation ARC Leopold Griffuel Prize for Clinical and Translational Cancer Research
- Mar. 23, 2021
- First drug approved for unresectable thymic carcinoma
- Feb. 15, 2021
- NCC Leadership Courtesy Visit to His Excellency the Ambassador of France
- Feb. 2, 2021
- Deep Vision: Near-Infrared Imaging and Machine Learning Can Identify Hidden Tumors
- Dec. 25, 2020
- Japan-China-Korea ASEAN
Cancer Registration and Cancer Control Course - Dec. 25, 2020
- Three Researchers from National Cancer Center on “Highly Cited Researchers 2020” List
- Dec. 20, 2020
- Construction Begins on the“Kashiwa-no-ha Hotel Project (tentative name)”to Create a New Clinical Model in Kashiwa-no-ha
- Nov. 27, 2020
- Royal Thai Embassy HE Ambassador Mr Singtong Lapisatepun Visit
- Nov. 25, 2020
- Hiroyoshi Nishikawa Elected AAAS Fellow
- Nov. 17, 2020
- Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’
- Nov. 13, 2020
- Second ANCCA High Level Video Conference
- Oct. 26, 2020
- The 8th NCC-IARC Seminar on Childhood Cancer
- Oct. 9, 2020
- C/Can Digital Health Discovery Forum
Asia Regional Expert Dialogues - Oct. 6, 2020
- Development of Precision Medicine for Gastrointestinal Cancers Utility of Liquid Biopsy in Genomic Analysis
- Oct. 1, 2020
- Japan-China-Korea Cancer Control Workshop
- Sep. 11, 2020
- MOU signed with Tianjin Medical University Cancer Institute & Hospital
- Sep. 9, 2020
- Asian early phase drug development network
ATLAS Project – Paving the way towards developing drugs with Asian partners - Sep. 1, 2020
- A novel biomarker for predicting clinical efficacy of PD-1 blockade therapies
- Aug. 28, 2020
- MOU signed with Ho Chi Minh City Oncology Hospital（HCMCOH）in Vietnam
- Aug. 20, 2020
- NCC joins GSK’s oncology development network
- Jul. 3, 2020
- The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluate a SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
- Jun. 22, 2020
- National Cancer Center Japan and Mitsui Fudosan Agree on Accommodation Facility at the National Cancer Center Hospital East in Kashiwa-no-ha Smart City
- Jun. 11, 2020
- Dr. Manami Inoue nominated Scientific Council Member of IARC
- Apr. 28, 2020
- Japan-China-Korea National Cancer Centers
Covid-19 Infection Control Meeting - Apr. 9, 2020
- Novel oncogenic mechanism identified through a comprehensive pan-cancer genomic study
－application in cancer precision medicine anticipated－ - Apr. 1, 2020
- Advanced Medical Care Approval for Cancer Gene Panel Testing at the Time of Initial Treatment
- Prospective Study to Assess the Feasibility and Clinical Utility of Comprehensive Genomic Profiling at the Time of Initial Treatment of Patients with Solid Tumors - - Mar. 24, 2020
- coronavirus outbreak response update
- Mar. 17, 2020
- Notice in response to coronavirus outbreak
- Mar. 2, 2020
- HE Professor Tomasz Grodzki, Polish Senate Marshal visit
- Feb. 26, 2020
- WHO and IARC Cancer Reports Published
- Feb. 20, 2020
- Franco-Japanese Pediatric Cancers Workshop
- Feb. 17, 2020
- Global Consortium Completes Tumor Analyses Project
- Feb. 10, 2020
- Cancer Registration Training in Lao PDR
- Jan. 31, 2020
- In due respect to global efforts to contain the spread of new coronavirus, the National Cancer Center of Japan requests your kind cooperation for the welfare of our patients.
- Jan. 29, 2020
- Clinical Trial Investigators visit NCC Hospital
- Jan. 24, 2020
- IAEA workshop at NCC
- Dec. 16, 2019
- ANCCA High Level video conference and Website GoLive
- Dec. 11, 2019
- Test Result of New Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting Proves Higher Efficacy Than Standard Antiemetic Therapy
- Nov. 8, 2019
- Quality Control Training for Cancer Registry in Myanmar
- Nov. 7, 2019
- Commencement of Clinical Trial of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma and Angiosarcoma
- Sep. 30, 2019
- Cancer Registration Training in Vietnam
- Aug. 16, 2019
- Proposed Operational Plan and Recommendations for Cancer Registration in Myanmar
- Aug. 13, 2019
- Cancer Statistics in Japan; Table download
- May 29, 2019
- Cancer Gene Panel Test OncoGuideTM NCC Oncopanel System added to Health Insurance Coverage list
- May 23, 2019
- New Memorandum of Understanding signed with Cancer Center at Beth Israel Deaconess Medical Center
- Apr. 22, 2019
- The Hon Mrs Carrie Lam, HKSAR Chief Executive visit
- Apr. 16, 2019
- Dr Yasuhiro Fujiwara hosted by National Cancer Center in Beijing
- Mar. 28, 2019
- National Cancer Center Japan and IARC’s Joint Seminar 6
- Mar. 26, 2019
- Launch a joint research project on a new cancer immunotherapy using liposome, a drug delivery system technology
－Goal is to identify its actions on immune cells, and elucidate the mechanism by which survival periods are extended－ - Mar. 7, 2019
- Kazakhstan Delegation visit
- Feb. 12, 2019
- UK Genomics Delegation visit
- Jan. 23, 2019
- National Cancer Center Japan and IARC’s Joint Seminar 5
- Jan. 22, 2019
- MoU (Memorandum of Understanding) signed with National Cancer Institute, Thailand
- Jan. 22, 2019
- Dr Kazuaki Shimada appointed Honorary Professor at Tianjin Medical University Cancer Institute and Hospital
- Dec. 10, 2018
- Asian National Cancer Centers Alliance (ANCCA) - 7th Meeting in Jakarta, Indonesia
- Nov. 26, 2018
- National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’ Towards coverage under national health insurance system
- Nov. 19, 2018
- Action across borders
- Nov. 19, 2018
- Quickening the pace of new anti-cancer agents Attracting nanoparticles full of cancer drugs to the stroma of a tumour is proving key to new therapeutics.
- Nov. 13, 2018
- Hospital East honoured at ESMO
- Nov. 12, 2018
- Facilitating International Clinical Trials Initiated by
Japanese Academic Institutions
Japan-led Global Investigator-Initiated Registration-Directed Trial of Advanced or Metastatic Breast Cancer (PATHWAY trial) Has Started - Oct. 12, 2018
- Cancer Registration Training at Cambodia and Viet Nam
- Oct. 1, 2018
- National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment
- Sep. 18, 2018
- Visit to Norman E. Sharpless MD and his delegation at the National Cancer Institute
- Sep. 15, 2018
- Projected Cancer Statistics, 2018
- Aug. 22, 2018
- National Cancer Center Japan - IARC Seminar 4
- Aug. 8, 2018
- Dr Masaaki Ito appointed Honorary Professor at China-Japan Friendship Hospital
- Aug. 2, 2018
- Organization Chart Updated
- Jun. 27, 2018
- Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
- Jun. 1, 2018
- NCC Establishes Center for Cancer Genomics and Advanced
Therapeutics (C-CAT) to Aggregate and Manage Information on
Cancer Genomic Medicine and Promote Its Use - May 28, 2018
- New Agreement with National Cancer Hospital, Vietnam
- May 7, 2018
- National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
- Apr. 23, 2018
- National Cancer Center – IARC Seminar 3
- Apr. 3, 2018
- National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system - Apr. 3, 2018
- Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine - Mar. 30, 2018
- NCC joins China and Korea at the first 3 national cancer centers’ workshop
- Mar. 19, 2018
- Cancer Registration Seminar in Indonesia
- Mar. 13, 2018
- SCRUM-Japan GI-SCREEN Aims for Realizing of Cancer Precision Medicine Utilizing Liquid Biopsy by Analyzing Comprehensive Cancer Genome Alterations in Blood
- Mar. 9, 2018
- WHO Classification of Tumours Series appoints Dr Ochiai to Editorial Board
- Feb. 14, 2018
- A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects - Feb. 5, 2018
- Maestro Chung Visit
- Jan. 23, 2018
- Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style - Dec. 22, 2017
- T. Matsuda takes office of International Association of Cancer Registries President
- Dec. 18, 2017
- Cancer Statistics in Japan; Table download
- Dec. 14, 2017
- National Cancer Center - IARC Seminar 2
- Dec. 5, 2017
- NCC signs comprehensive MoU with WHO/IARC
- Nov. 27, 2017
- Asian Early Phase Oncology Drug Development Consortium Formed
- Nov. 21, 2017
- New Agreement with National Cancer Center, Indonesia
- Nov. 14, 2017
- Lithuanian Health Minister Visit
- Oct. 30, 2017
- Cancer Statistics in Japan; Table download
- Oct. 27, 2017
- Collaborative Research on Fully-personalized Cancer Neoantigen Vaccine
- Oct. 27, 2017
- Projected Cancer Statistics, 2017
- Oct. 26, 2017
- National Cancer Center - IARC Seminar 1
- Oct. 16, 2017
- Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
- Aug. 3, 2017
- Japan-Singapore lead international research in discovering potential targeted treatments for biliary tract cancer
- Aug. 1, 2017
- On-Table Adaptive Radiation Therapy
- Jul. 31, 2017
- The MASTER KEY PROJECT
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia - Jul. 21, 2017
- Cancer Registration Seminar in Myanmar
- Jul. 11, 2017
- Cancer Statistics in Japan; Table download（Link to Cancer Information Service）
- Jun. 26, 2017
- A novel biomarker for development of a new screening technique for early-stage pancreatic cancer and precancerous conditions associated with risk of pancreatic malignancy - experimental screening in Kagoshima Prefecture
- Jun. 16, 2017
- National Cancer Center hosts Iranian Delegation
- May 30, 2017
- WHO/International Agency for Research on Cancer establishes National Cancer Center as Global Initiative for Cancer Registry Development Collaborating Centre
- Apr. 27, 2017
- Elucidation of the mechanism of MLL-rearranged leukemia Use of two molecularly targeted drugs as novel therapy
- Mar. 1, 2017
- Commencement of Phase 1 Trial for the Mutant IDH1 Inhibitor (DS-1001)Targeting Malignant Brain Tumors
- Feb. 28, 2017
- Malignant extracellular vesicles derived from ovarian cancer cells facilitate peritoneal dissemination, and the vesicles can be promising targets for improving patient outcomes.
- Feb. 21, 2017
- Signing MOU with the National Cancer Research Institute (UK)